Weight gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA era.

scientific article

Weight gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA era. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1158/1940-6207.CAPR-10-0257
P932PMC publication ID3072036
P698PubMed publication ID21325564

P50authorPatrick Craig WalshQ2057508
Alison M MondulQ54269242
Corinne JoshuQ61196478
Elizabeth A PlatzQ89968613
Andy MenkeQ114452415
P2093author name stringStephen J Freedland
Misop Han
Elizabeth B Humphreys
Cari Meinhold
P2860cites workInflammation and insulin resistanceQ22241893
Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE.Q31018353
Obesity and prostate cancer: making sense out of apparently conflicting dataQ31111552
Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomyQ34285704
Impact of body mass index on biochemical recurrence rates after radical prostatectomy: an analysis utilizing propensity score matchingQ35966836
The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreasQ36820202
Relationship of body mass, height, and weight gain to prostate cancer risk in the multiethnic cohortQ37343281
Age-specific physical activity and prostate cancer risk among white men and black menQ37399743
A prospective study of lifetime physical activity and prostate cancer incidence and mortalityQ37457720
Height, body weight, and risk of prostate cancerQ39451325
Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancerQ39573788
Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortalityQ39781055
Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomyQ40431540
Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study groupQ42616120
Implications of body mass index in Japanese patients with prostate cancer who had undergone radical prostatectomyQ43197453
Body mass index is not a prognostic marker for prostate-specific antigen failure and survival in Dutch men treated with brachytherapy.Q45929455
Relationship between obesity and race in predicting adverse pathologic variables in patients undergoing radical prostatectomyQ46398680
Influence of body mass index and total testosterone level on biochemical recurrence following radical prostatectomyQ46748487
Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomyQ47366439
Case-control study of anthropometric measures and prostate cancer riskQ47802428
Body mass index as a prognostic marker for biochemical recurrence in Dutch men treated with radical prostatectomy.Q51819089
Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study.Q54229593
Physical activity and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohortQ57271387
Obesity and hormone-dependent tumors: Cohort and co-twin control studies based on the Swedish Twin RegistryQ57697495
Body Mass Index and Prostate Specific Antigen as Predictors of Adverse Pathology and Biochemical Recurrence After ProstatectomyQ57989646
Anthropometrics and Prostate Cancer RiskQ58394394
Body mass index as a predictor of cancer in menQ69833748
Family history of prostate cancer and obesity in relation to high-grade disease and extraprostatic extension in young men with prostate cancerQ73182302
Association of smoking, body mass, and physical activity with risk of prostate cancer in the Iowa 65+ Rural Health Study (United States)Q73304481
Epidemiologic determinants of clinically relevant prostate cancerQ73911397
Lifestyle and anthropometric risk factors for prostate cancer in a cohort of Iowa menQ74238943
Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancerQ79794785
Effect of obesity on prostate-specific antigen recurrence after radiation therapy for localized prostate cancer as measured by the 2006 Radiation Therapy Oncology Group-American Society for Therapeutic Radiation and Oncology (RTOG-ASTRO) Phoenix conQ80574708
Obesity as a predictor of biochemical recurrence and survival after radiation therapy for prostate cancerQ80580889
Obesity and risk of biochemical progression following radical prostatectomy at a tertiary care referral centerQ81044159
Body mass index trends and role of obesity in predicting outcome after radical prostatectomyQ81582595
Stronger association between obesity and biochemical progression after radical prostatectomy among men treated in the last 10 yearsQ81662282
Obesity and risk of biochemical failure for patients receiving salvage radiotherapy after prostatectomyQ81792275
Obesity and survival after radical prostatectomy: A 10-year prospective cohort studyQ83989911
P433issue4
P921main subjectprostate cancerQ181257
weight gainQ3403879
P304page(s)544-551
P577publication date2011-02-16
P1433published inCancer Prevention ResearchQ2665103
P1476titleWeight gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA era.
P478volume4

Reverse relations

cites work (P2860)
Q47621827"We're Just Not Prepared for Eating Over Our Whole Life": A Mixed Methods Approach to Understanding Dietary Behaviors Among Longer Term Cancer Survivors
Q38021854A critical evaluation of body composition modalities used to assess adipose and skeletal muscle tissue in cancer
Q90287245Adding the Team into T1 Translational Research: A Case Study of Multidisciplinary Team Science in the Evaluation of Biomarkers of Prostate Cancer Risk and Prognosis
Q47173681Body mass index and weight change in men with prostate cancer: progression and mortality
Q35033571Capitalizing on the "teachable moment" to promote healthy dietary changes among cancer survivors: the perspectives of health care providers
Q92410853Diet and Lifestyle in Prostate Cancer
Q40907943Effect of a 2-year home-based endurance training intervention on physiological function and PSA doubling time in prostate cancer patients.
Q36275355Exploring important influences on the healthfulness of prostate cancer survivors' diets
Q35842158Fat intake after prostate cancer diagnosis and mortality in the Physicians' Health Study
Q46344452Fatty liver disease as a predictor of local recurrence following resection of colorectal liver metastases
Q36080332Heart healthy equals prostate healthy and statins, aspirin, and/or metformin (S.A.M.) are the ideal recommendations for prostate cancer prevention
Q86927922Impact of body mass index on clinicopathological outcome and biochemical recurrence after radical prostatectomy
Q37180380Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity
Q27025735Lifestyle and dietary factors in the prevention of lethal prostate cancer
Q100736589Long-chain acyl-CoA synthetase 4-mediated fatty acid metabolism sustains androgen receptor pathway-independent prostate cancer
Q36636102Making the most of the imaging we have: using head MRI to estimate body composition
Q35584673Maximizing benefits for effective cancer survivorship programming: defining a dissemination and implementation plan
Q38005959Nutrition and physical activity guidelines for cancer survivors
Q50856725Obesity and Prostate Cancer.
Q26786829Obesity and cancer: mechanistic insights from transdisciplinary studies
Q36685022Obesity and prostate cancer: weighing the evidence
Q37971322Potential for prostate cancer prevention through physical activity
Q42615368Preoperative weight change and risk of adverse outcome following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital database
Q36748541Preventing aggressive prostate cancer with proven cardiovascular disease preventive methods
Q33802558Prostate cancer progression and mortality: a review of diet and lifestyle factors
Q40214047Prostate cancer: Is active surveillance safe for obese patients?
Q96432088Prostate carcinogenesis: inflammatory storms
Q40707324Should visceral fat, strictly linked to hepatic steatosis, be depleted to improve survival?
Q35734783Survivorship: nutrition and weight management, Version 2.2014. Clinical practice guidelines in oncology
Q52725879The Epidemiology of Prostate Cancer.
Q47173173The association of weight change in young adulthood and smoking status with risk of prostate cancer recurrence
Q37173902The impact of obesity on prostate cancer recurrence observed after exclusion of diabetics
Q40185822Weight change, obesity and risk of prostate cancer progression among men with clinically localized prostate cancer

Search more.